Skinvisible, Inc.
SKVI
$0.58
$0.047.41%
09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Revenue | 0.00% | 0.00% | 0.00% | 0.00% | -46.24% |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 0.00% | 0.00% | 0.00% | 0.00% | -46.24% |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | 0.00% | 0.00% | 0.00% | 0.00% | -16.67% |
SG&A Expenses | 9.15% | 26.46% | -3.74% | 15.93% | -11.60% |
Depreciation & Amortization | 31.11% | 0.00% | 2.17% | 0.00% | -4.26% |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 10.08% | 25.38% | -3.54% | 15.32% | -13.48% |
Operating Income | -10.52% | -26.51% | 3.67% | -15.97% | 11.08% |
Income Before Tax | 0.31% | -9.89% | 80.83% | 24.16% | 31.24% |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | 0.31% | -9.89% | 80.83% | 24.16% | 31.24% |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | 0.31% | -9.89% | 80.83% | 24.16% | 31.24% |
EBIT | -10.52% | -26.51% | 3.67% | -15.97% | 11.08% |
EBITDA | -9.58% | -27.69% | 3.89% | -16.64% | 11.27% |
EPS Basic | 0.32% | -9.87% | 80.82% | 24.15% | 31.27% |
Normalized Basic EPS | 0.25% | -10.00% | 80.82% | 24.14% | 31.25% |
EPS Diluted | 0.32% | -15.13% | 80.82% | 25.67% | 31.27% |
Normalized Diluted EPS | 0.25% | -7.63% | 80.82% | 24.14% | 31.25% |
Average Basic Shares Outstanding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Average Diluted Shares Outstanding | 0.00% | 2.20% | 0.00% | 0.00% | 0.00% |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |